Avior Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-26
Closed -$408 – 3178
2024
Q1
$408 Buy
+26
New +$401 ﹤0.01% 2619

Other funds holding NEO

Avior Wealth Management's NEO Position: Q2 2024 in Review

Avior Wealth Management sold out of NeoGenomics (NEO) in Q2 2024, closing a stake of 26 shares — an estimated $408 sold.

Avior Wealth Management first reported a position in NEO in Q1 2024 and held it in 1 quarter. The position peaked at $408 in Q1 2024. 259 funds tracked by Wall St. Rank hold NEO as of Q2 2024.

  • Avior Wealth Management reported no remaining NeoGenomics position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 26 NeoGenomics shares in Q2 2024, an estimated $408.
  • Avior Wealth Management first reported a position in NeoGenomics in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's NeoGenomics position peaked at $408 in Q1 2024.
  • 259 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.